EOS-003 (Eos Therapies)

N/A

Report date: 2025/01/17 15:10:46
NME

Base Information

Drug NameEOS-003 (Eos Therapies)
Drug Alias NameEOS-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 2 antagonistsToll like receptor 9 antagonists
TargetsToll like receptor 2Toll like receptor 9
Therapy Area/IndicationsNeurodegenerative DiseasesParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEos Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesEos Therapies Inc
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A